Cargando…

Go Where the Virus Is: An HIV Micro-epidemic Control Approach to Stop HIV Transmission

Essentially all HIV transmission is from people living with HIV who are not virally suppressed. An HIV micro-epidemic control approach that differentiates treatment support and prevention services for people living with HIV and their network members according to viral burden could optimize the impac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cassell, Michael M., Wilcher, Rose, Ramautarsing, Reshmie A., Phanuphak, Nittaya, Mastro, Timothy D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Global Health: Science and Practice 2020
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7784070/ https://www.ncbi.nlm.nih.gov/pubmed/33361230 http://dx.doi.org/10.9745/GHSP-D-19-00418

Ejemplares similares

Leveraging early HIV diagnosis and treatment in Thailand to conduct HIV cure research
por: Muccini, Camilla, et al.
Publicado: (2019)

Certification of lay providers to deliver key population‐led HIV services in Thailand's National Healthcare System: lessons learned
por: Pengnonyang, Supabhorn, et al.
Publicado: (2022)

Implementing a Status-Neutral Approach to HIV in the Asia-Pacific
por: Phanuphak, Nittaya, et al.
Publicado: (2020)

Acceptability and retention of the key population‐led HIV treatment service for men who have sex with men and transgender women living with HIV in Thailand
por: Lujintanon, Sita, et al.
Publicado: (2023)

Uptake of Primary Care Services and HIV and Syphilis Infection among Transgender Women attending the Tangerine Community Health Clinic, Bangkok, Thailand, 2016 – 2019
por: van Griensven, Frits, et al.
Publicado: (2021)

The question of the question: impactful implementation science to address the HIV epidemic
por: Geng, Elvin H., et al.
Publicado: (2022)

History of the prevention of mother-to-child transmission of HIV in Thailand
por: Phanuphak, Nittaya, et al.
Publicado: (2016)

Expanding reimbursement of immediate treatment using direct acting antivirals to reduce hepatitis C incidence among HIV positive men who have sex with men in Bangkok, Thailand: A cost effectiveness modelling study
por: Mukherjee, Shreoshee, et al.
Publicado: (2021)

Prevalence and the associated factors of hepatitis B and hepatitis C viral infections among HIV-positive individuals in same-day antiretroviral therapy initiation program in Bangkok, Thailand
por: Thitipatarakorn, Supanat, et al.
Publicado: (2022)

Overcoming challenges across the HIV care continuum in the Asia-Pacific region: expert recommendations
por: Choi, Jun Yong, et al.
Publicado: (2023)

Cervical and anal HPV infection: cytological and histological abnormalities in HIV-infected women in Thailand
por: Ramautarsing, Reshmie A, et al.
Publicado: (2015)

Client and provider preferences for HIV care: Implications for implementing differentiated service delivery in Thailand
por: Lujintanon, Sita, et al.
Publicado: (2021)

Commentary: Round and round the mesenchymal stromal cells go; where they stop, we hope to know
por: Matte, Gregory S., et al.
Publicado: (2021)

Bone mineral density changes among people living with HIV who have started with TDF-containing regimen: A five-year prospective study
por: Han, Win Min, et al.
Publicado: (2020)

Putting women in the centre of the global HIV response is key to achieving epidemic control!
por: Abdool Karim, Quarraisha, et al.
Publicado: (2020)

Give the community the tools and they will help finish the job: key population‐led health services for ending AIDS in Thailand
por: Vannakit, Ravipa, et al.
Publicado: (2020)

Prevalence of and risk factors for anal high-risk HPV among HIV-negative and HIV-positive MSM and transgender women in three countries at South-East Asia
por: Somia, I Ketut Agus, et al.
Publicado: (2018)

Hitting HIV where it hides
por: Dayton, Andrew I
Publicado: (2008)

The importance of addressing gender inequality in efforts to end vertical transmission of HIV
por: Ghanotakis, Elena, et al.
Publicado: (2012)

Where is biological therapy going?
por: Schulze-Koops, Hendrik, et al.
Publicado: (2000)

Key population-led community-based same-day antiretroviral therapy (CB-SDART) initiation hub in Bangkok, Thailand: a protocol for a hybrid type 3 implementation trial
por: Lujintanon, Sita, et al.
Publicado: (2022)

Evaluation of a pre‐exposure prophylaxis programme for men who have sex with men and transgender women in Thailand: learning through the HIV prevention cascade lens
por: Ramautarsing, Reshmie A, et al.
Publicado: (2020)

Stopping epidemics when and where they occur
por: Torreele, Els, et al.
Publicado: (2023)

Lessons for the HIV response from structural innovations catalysed by COVID-19
por: Isbell, Michael, et al.
Publicado: (2022)

AI in medicine: Where are we now and where are we going?
por: Shandhi, Md Mobashir Hasan, et al.
Publicado: (2022)

Pregnant adolescents living with HIV: what we know, what we need to know, where we need to go
por: Callahan, Tegan, et al.
Publicado: (2017)

Treatment-as-prevention: stopping the epidemic of HIV
por: Williams, B
Publicado: (2010)

The epidemiological impact and cost-effectiveness of key population-led PrEP delivery to prevent HIV among men who have sex with men in Thailand: A modelling study
por: Versteegh, Lisbeth, et al.
Publicado: (2022)

The economics of stop-and-go epidemic control
por: Gros, Claudius, et al.
Publicado: (2022)

Same‐day antiretroviral therapy initiation hub model at the Thai Red Cross Anonymous Clinic in Bangkok, Thailand: an observational cohort study
por: Seekaew, Pich, et al.
Publicado: (2021)

Accountability in clinical trial diversity: The buck stops where?
por: Nephew, Lauren D.
Publicado: (2021)

Breast cancer research: where we are and where we should go
por: Liu, Edison T
Publicado: (2000)

ARV-based HIV prevention for women – where we are in 2014
por: Mastro, Timothy D, et al.
Publicado: (2014)

Community participation in HIV cure research: perspectives from Thailand
por: Phanuphak, Nittaya, et al.
Publicado: (2015)

Glucagon-Like Peptide 1 in the Brain: Where Is It Coming From, Where Is It Going?
por: Daniels, Derek, et al.
Publicado: (2019)

Predicting Molecular Models: Where Are We Going?
por: Ratta, Raffaele, et al.
Publicado: (2015)

Proliferation/Quiescence: When to start? Where to stop? What to stock?
por: Daignan-Fornier, Bertrand, et al.
Publicado: (2011)

Stop-and-Go: Dynamics of Nucleolar Transcription During the Cell Cycle
por: Iyer-Bierhoff, Aishwarya, et al.
Publicado: (2019)

The path to equitable HIV prevention
por: Idoko, John Alechenu, et al.
Publicado: (2022)

Commentary: Retinoblastoma management—Where are we and where do we go from here?
por: Shanmugam, P Mahesh
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8qs1qiku4t7r22f5qp9h5tvd0r